Dr. Alex Wiechmann is a residency trained doctor in ocular disease and refractive surgery management. She is the externship director for the Rosenberg School of Optometry 4th year optometry students, educating them on collaborative care and management of refractive surgery and ocular disease. After honing her skills for 10 years, Dr. Wiechmann has become the face of Modern LASIK.
As a past LASIK patient herself, she offers a real perspective on how LASIK works and how it can change your life. She has helped thousands of patients answer the questions, “Am I candidate for LASIK?” and “What procedure is best for me?” With the introduction of SMILE LASIK and implantable contact lenses in the U.S. market, Dr. Wiechmann can offer all of the latest technologies to get patients out of glasses and contacts.
She is passionate in providing personalized care that meets her patient’s needs, no matter how unique they may be.
She is also a faculty member of the Refractive Surgery Alliance Society Grand Rounds Collaborative Care Series providing continuing education to doctors around the world.
Specialties
- LASIK Eye Surgery Consults
- Laser Eye Surgery Consults
- SMILE LASIK Consults
- EVO ICL Consults
- Laser Eye Surgery Consults
- Cataract Surgery Evaluations
- Ocular Pathology
- Dry Eye Treatment
- Keratoconus Evaluations
- Glaucoma Assessment and Treatment
- Ocular Disease
- Surgical Co-Management
An Open Letter to My Patients
I first realized I needed something to help me see clearly in the 9th grade. I couldn’t see the board in Biology class and that next week I was prescribed glasses. Glasses quickly got in the way when trying to read music on a music stand or running around a tennis court. Contact lenses became my new normal. I always imagined what it would be like to just be able to wake up and see. I was wearing my contact lenses for so many hours a day which led to contact lens related dryness and irritation. I remember my eye doctor trying many different types of contact lens brands to try and help the issue. I didn’t realize refractive surgery was an option for me until becoming a resident at Parkhurst NuVision and having a refractive consultation myself.
LASIK has helped my dryness and allowed me to wake up and immediately start my day without even thinking about putting something on my face or in my eyes to function. It has been a life changing experience and I want to share that with all my patients.
“I wish I would have done this sooner!” is what I routinely hear after refractive procedures. Being part of a world-class team has allowed me to help people everyday from all over and I am so blessed to be part of your journey in achieving your best natural vision.
With warm regards,
Dr. Alex Wiechmann
Education & Experience
Dr. Alex Wiechmann graduated from the University of Texas at Austin and the University of the Incarnate Word, Rosenberg School of Optometry.
She completed a residency in refractive surgery and ocular disease at Parkhurst NuVision.
Professional Affiliations
- Director of Refractive Surgery Alliance Internship Program
- Refractive Surgery Alliance Continuing Education Faculty Member
- American Academy of Optometry
- American Optometric Association
- Texas Optometric Association
Research & Academics
- A Prospective, Multicenter, Non-Randomized Clinical Trial Designed to Evaluate the Safety and Effectiveness of the ELIOS System to Reduce Intraocular Pressure in Patients with Primary Open-Angle Glaucoma Undergoing Cataract Surgery (2022-Present)
- A Prospective Observational Clinical Trial Assessing Clinical Safety and Efficacy in Patients who Receive a Vivity Intraocular Lens in Eyes with Previous Hyperopic LASIK/PRK. (2022-Present)
- A Prospective, Multicenter, Randomized, Active-Controlled Clinical Study to Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction. (2021-Present)
- Clinical Evaluation of the Vision Performance of Tecnis Eyhance™ Intraocular Lenses with Tecnis Simplicity™ as Compared to Tecnis® 1-Piece Intraocular Lenses. (2021-Present)
- A Phase 2b/3, Randomized, Double-Masked, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Two Concentrations (0.4% and 1%) of ALY688 Ophthalmic Solution in Subjects with Dry Eye Disease (OASIS-1). (2021-Present)
- A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the MEL90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. (2021-Present)
- A Randomized, Placebo- Controlled, Double-Masked, Multicenter, Dosing-Range Study to Evaluate the Safety, and Efficacy of UNR844 in Subjects with Presbyopia. (2021-Present)
- Prospective, Randomized, Masked, Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare System in the Treatment of the Signs and Symptoms of Dry Eye Disease (SAHARA). (2021-Present)
- Post-Approval Study of the Panoptix Trifocal Lens in Patients Who Have had Post-Refractive Myopic Laser Vision Correction Surgery. (2021-Present)
- A Randomized, Double-Masked, Multicenter Study to Evaluate the Safety and Efficacy of ECF843 vs Vehicle in Subjects with Dry Eye Disease. (2021-2021)
- Effect of Cequa in Subjects With Dry Eye Disease That is Currently Inadequately Controlled While on Cyclosporine 0.05% Ophthalmic Emulsion. (2020-Present)
- A Multicenter Clinical Evaluation of the EVO/EVO+ Visian Implantable Collamer Lens. (2020-Present)
- Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare System in the Treatment of the Signs and Symptoms of Dry Eye Disease. (2019-2020)
- Prospective, Controlled, Randomized Bilateral and Non-Randomized Unilateral, Multicenter Clinical Investigation of the SC9 Extended Depth of Focus Intraocular Lens compared with Control (Bausch & Lomb Monofocal LI61SE Intraocular Lens). (2019-Present)
- Post-Approval Study to Evaluate the Rates of Bothersome Visual Symptoms in a Larger Population in Clinical Practice for the Tecnis Symfony Toric IOLs with Approximately 2.0 D or More of Cylinder Correction at the Corneal Plane Compared with Approximately 1.0 D of Cylinder Correction at the Corneal Plane and to Ensure the Continued Safety of the Approved Devices. (2019-2021)
- Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5%. (2018-Present)
Honors, Distinctions, & Publications
Honors & Distinctions
- Gold Key International Optometric Honor Society – Former Vice-President
- Former Trustee of the American Optometric Student Association (2016-2018)
- Davis Eyecare in Chicago Optometric Clinical Externship – Contact lens specialty and keratoconus
- Brooke Army Medical Center’s Troop Medical Clinic at Fort Sam Houston Optometric Clinical Externship – Ocular pathology and primary care
- Surgical Mission Trip – Performed pre and postoperative care after cataract surgery in Guerrero, Mexico
- Obtained Student Fellowship in the American Academy of Optometry
Publications
- CRST Publication: Refractive Surgery in a COVID Environment
- Review of Optometry: The Key to a Happy Refractive Surgery Patient
- American Academy of Optometry Abstract: Young post-vitrectomy myope seeking independence from spectacles
- American Academy of Optometry Abstract: Retrospective Review on Visual and Refractive Outcomes of a new Trifocal Intraocular Lens
- Continuing Education: Narrow Angles and the Deathly Hallow
- Continuing Education: Trifocal IOLs now here in the United State
- Continuing Education: Changing Clinic Protocols in a COVID Environment
Personal
Commitment to Community
Dr. Wiechmann is a native to San Antonio and is thankful to be able to serve NuVision patients. She is actively involved with Junior League of San Antonio, an organization of women committed to promoting voluntarism and developing the potential of women. She currently sits on the Junior League’s Community Council Executive Committee. In her spare time, she enjoys traveling and hiking with her husband.
